摩根大通增持信达生物约40.86万股 每股作价约84.94港元

Group 1 - Morgan Stanley increased its stake in Innovent Biologics (01801) by 408,630 shares at a price of HKD 84.9352 per share, totaling approximately HKD 34.7071 million [1] - After the increase, the total number of shares held by Morgan Stanley is approximately 86,908,100, representing a holding percentage of 5% [1]